Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2014; 139(14): 704-706
DOI: 10.1055/s-0034-1369841
DOI: 10.1055/s-0034-1369841
Nephrologie | Commentary
Nephrologie, Diabetologie
Diabetische Nephropathie: Neues in Diagnose, Prävention und Therapie
Diabetic nephropathy: new insights into diagnosis, prevention and treatmentFurther Information
Publication History
Publication Date:
25 March 2014 (online)
-
Literatur
- 1 Action to Control Cardiovascular Risk in Diabetes Study Group, . Gerstein HC, Miller ME, Byington RP et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545-2559
- 2 Advance Collaborative Group, . Patel A, MacMahon S, Chalmers J et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-2572
- 3 Böger CA, Sedor JR. GWAS of diabetic nephropathy: is the GENIE out of the bottle?. PLoS Genet 2012; 8: e1002989
- 4 Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Therapie des Typ-2-Diabetes–Langfassung . 1. Auflage. Version 1 2013. http://www.versorgungsleitlinien.de/themen/diabetes2/dm2_Therapie (letzter Zugriff 11.2.2014)
- 5 Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale Versorgungsleitlinie Nierenerkrankungen bei Diabetes im Erwachsenenalter – Langfassung . 1. Auflage. Version 5 2010. (zuletzt verändert Mai 2013.) http://www.diabetes.versorgungsleitlinien.de (letzter Zugriff 11.2.2014)
- 6 Fox CS, Matsushita K, Woodward M et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet 2012; 380: 1662-1673
- 7 Haider DG, Peric S, Friedl A et al. Kidney biopsy in patients with diabetes mellitus. Clin Nephrol 2011; 76: 180-185
- 8 Inzucchi SE, Bergenstal RM, Buse JB et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2012; 55: 1577-1596
- 9 KDIGO. KDIGO Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int Suppl 2012; 2
- 10 KDIGO. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013; 3: 1-150
- 11 Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281-1357
- 12 Nathan DM, Cleary PA, Backlund JY et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353: 2643-2653
- 13 Perkins BA, Ficociello LH, Roshan B et al. In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria. Kidney Int 2010; 77: 57-64
- 14 Sacks DB, Arnold M, Bakris GL et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care 2011; 34: e61-99
- 15 Tervaert TW, Mooyaart AL, Amann K et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol 2010; 21: 556-563